BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10582802)

  • 1. Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer.
    Imoto S; Murakami K; Ikeda H; Fukukita H; Moriyama N
    Ann Nucl Med; 1999 Oct; 13(5):325-9. PubMed ID: 10582802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of lymphoscintigraphic mapping with Tc-99m human serum albumin and tin colloid in sentinel lymph node biopsy in breast cancer.
    Kim R; Osaki A; Kojima J; Toge T
    Int J Oncol; 2001 Nov; 19(5):991-6. PubMed ID: 11604999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node identification with radiopharmaceuticals in patients with breast cancer: a comparison of 99mTc-tin colloid and 99mTc-phytate efficiency.
    Seok JW; Choi YS; Chong S; Kwon GY; Chung YJ; Kim BG; Park SJ
    Breast Cancer Res Treat; 2010 Jul; 122(2):453-7. PubMed ID: 20532977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
    Babiera GV; Delpassand ES; Breslin TM; Ross MI; Ames FC; Singletary SE; Kuerer HM; Feig BW; Meric-Bernstam F; Hunt KK
    Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
    Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
    J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
    De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
    J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer.
    Yararbas U; Argon AM; Yeniay L; Zengel B; Kapkaç M
    Nucl Med Biol; 2010 Oct; 37(7):805-10. PubMed ID: 20870155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma.
    Bedrosian I; Scheff AM; Mick R; Callans LS; Bucky LP; Spitz FR; Helsabeck C; Elder DE; Alavi A; Fraker DF; Czerniecki BJ
    J Nucl Med; 1999 Jul; 40(7):1143-8. PubMed ID: 10405134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of sentinel lymph node in stage I-II breast cancer with lymphoscintigraphy and surgical gamma probe: comparison of Tc-99m MIBI and Tc-99m sulfur colloid.
    Arcan P; Ibis E; Aras G; Cam R; Küçük NO
    Clin Nucl Med; 2005 May; 30(5):317-21. PubMed ID: 15827399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
    Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
    Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of subareolar injection lymphoscintigraphy with the 1-day and the 2-day protocols for the detection of sentinel lymph nodes in patients with breast cancer.
    Seok JW; Kim IJ; Heo YJ; Yang YJ; Choi YS; Kim BG; Park SJ
    Ann Nucl Med; 2009 Jul; 23(5):465-9. PubMed ID: 19452250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
    Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
    Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid.
    Kern KA; Rosenberg RJ
    J Am Coll Surg; 2000 Nov; 191(5):479-89. PubMed ID: 11085727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of 99mTc-HIG for sentinel lymph node mapping in breast cancer patients.
    Gencoglu EA; Yalcn H; Yagmurdur M; Ozen A; Basaran O; Karakayal F; Ekici Y; Karakayal H; Aktas A
    Nucl Med Commun; 2005 Sep; 26(9):781-6. PubMed ID: 16096581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node biopsy in primary breast cancer: radioactive detection and metastatic disease.
    Wada N; Sakemura N; Imoto S; Hasebe T; Ochiai A; Moriyama N
    Eur J Surg Oncol; 2007 Aug; 33(6):691-5. PubMed ID: 17258879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoscintigraphy for interpretation of changes of cervical lymph node function in patients with oral malignant tumors: comparison of Tc-99m-Re and Tc-99m-HSA-D.
    Sato T; Yamaguchi K; Morita Y; Noikura T; Sugihara K; Matsune S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):525-37. PubMed ID: 11027392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
    Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
    Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy of Tc-99m HIG and Tc-99m nanocolloid on sentinel lymph node mapping in patients with breast cancer.
    Yalçin H; Gençoglu EA; Yagmurdur M; Aras M; Ozen A; Aktas A
    Nucl Med Commun; 2010 Oct; 31(10):903-9. PubMed ID: 20683362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of the extraction fractions of nanocolloid and polyclonal immunoglobulin by axillary lymph nodes in patients with breast cancer.
    Fowler JC; Solanki CK; Barber RW; Swift EA; Guenther I; Ballinger JR; Purushotham AD; Peters AM
    Nucl Med Commun; 2004 Sep; 25(9):935-40. PubMed ID: 15319599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.